Insulet | Les Charges D'Exploitation

Prix De L'Action
245.61
Variation Quotidienne
3.68 1.52%
Mensuellement
-11.83%
Annuel
-13.92%
Q1 Prévisions
234.50




Les Charges D'Exploitation Changement Date
Abbott USD 9.21B 17M 2025-12
Align Technology USD 822.85M 11.8M 2025-12
AtriCure USD 134.06M 8.27M 2025-09
Avanos Medical USD 158.83M 69.83M 2025-09
Baxter International USD 2.63B 95.8M 2025-09
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Cardinal Health USD -2.88B 5M 2025-12
Cooper Companies USD 924.8M 40.2M 2025-09
Dexcom USD 966.8M 22.3M 2025-09
Edwards Lifesciences USD 1.13B 26.7M 2025-09
Eli Lilly USD 10.31B 1.09B 2025-12
Globus Medical USD 886.57M 730.06M 2025-09
ICU Medical USD 510.13M 11.93M 2025-09
Insulet USD 588.6M 60.6M 2025-09
Integra LifeSciences USD 1.04B 620.66M 2025-09
J&J USD 18.97B 2.38B 2025-12
Masimo USD 147M 159.4M 2025-09
Medtronic USD 7.26B 283M 2025-09
Merit Medical Systems USD 341.54M 6.11M 2025-09
Roche Holding CHF 21.01B 10.84B 2025-12
Solventum Corp USD 4.99B 3.04B 2025-09
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 272.12M 421K 2025-09
Teleflex USD 3.82B 3.22B 2025-09
West Pharmaceutical Services USD 3.05B 2.44B 2025-09
Zimmer Biomet Holdings USD 1.66B 17.8M 2025-09


Insulet Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.